{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:35:36Z","timestamp":1791462936837,"version":"4.3.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40620-020-00753-w","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T06:02:36Z","timestamp":1590559356000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8\u00a0years follow up"],"prefix":"10.1093","volume":"34","author":[{"given":"Lorenza Maria","family":"Argolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Frontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Elefante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Saccon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Binda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-476X","authenticated-orcid":false,"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"issue":"2","key":"753_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, Okeeffe AG, Su L et al (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55(2):252\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kev311","journal-title":"Rheumatology (Oxford)"},{"key":"753_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.med.52.1.63","volume":"52","author":"R Zimmerman","year":"2001","unstructured":"Zimmerman R, Radhakrishnan J, Valeri A et al (2001) Advances in the treatment of lupus nephritis. Annu Rev Med 52:63\u201378. https:\/\/doi.org\/10.1146\/annurev.med.52.1.63","journal-title":"Annu Rev Med"},{"key":"753_CR3","first-page":"9","volume":"23","author":"C Ponticelli","year":"2010","unstructured":"Ponticelli C, Glassock RJ, Moroni G (2010) Induction and maintenance therapy in proliferative lupus nephritis. J Nephrol 23:9\u201316","journal-title":"J Nephrol"},{"key":"753_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/ki.1996.528","volume":"50","author":"G Moroni","year":"1996","unstructured":"Moroni G, Quaglini S, Maccario M et al (1996) \u201cNephritic flares\u201d are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50:2047\u20132053. https:\/\/doi.org\/10.1038\/ki.1996.528","journal-title":"Kidney Int"},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/ki.1997.162","volume":"51","author":"MA Dooley","year":"1997","unstructured":"Dooley MA, Hogan S, Jennette C et al (1997) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular disease collaborative network. Kidney Int 51:1188\u20131195. https:\/\/doi.org\/10.1038\/ki.1997.162","journal-title":"Kidney Int"},{"key":"753_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0272-6386(99)70361-6","volume":"34","author":"CC Mok","year":"1999","unstructured":"Mok CC, Wong RWS, Lau CS (1999) Lupus nephritis in southern Chinese patients: clinicopathological findings and long term outcome. Am J Kidney Dis 34:315\u2013323. https:\/\/doi.org\/10.1016\/s0272-6386(99)70361-6","journal-title":"Am J Kidney Dis"},{"key":"753_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel GB, Contreras G, Dooley MA et al (2009) Aspreva Lupus Management Study Group: mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103\u20131112. https:\/\/doi.org\/10.1681\/ASN.2008101028","journal-title":"J Am Soc Nephrol"},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","volume":"365","author":"MA Dooley","year":"2011","unstructured":"Dooley MA, Jayne D, Ginzler EM et al (2011) ALMS Group, Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365:1886\u20131895. https:\/\/doi.org\/10.1056\/NEJMoa1014460","journal-title":"N Engl J Med"},{"key":"753_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1136\/ard.2010.131995","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, D'Cruz D, Sangle S et al (2010) MAINTAIN Nephritis Trial Group, Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial. Ann Rheum Dis 69:2083\u20132089. https:\/\/doi.org\/10.1136\/ard.2010.131995","journal-title":"Ann Rheum Dis"},{"key":"753_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2014-206897","volume":"75","author":"F Tamirou","year":"2016","unstructured":"Tamirou F, D'Cruz D, Sangle S et al (2016) MAINTAIN Nephritis Trial Group, Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis 75:526\u2013531. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206897","journal-title":"Ann Rheum Dis"},{"key":"753_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2215\/CJN.02271205","volume":"1","author":"G Moroni","year":"2006","unstructured":"Moroni G, Doria A, Mosca M et al (2006) A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol 1:925\u2013932. https:\/\/doi.org\/10.2215\/CJN.02271205","journal-title":"Clin J Am Soc Nephrol"},{"key":"753_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/0961203312442259","volume":"21","author":"W Chen","year":"2012","unstructured":"Chen W, Liu Q, Chen W et al (2012) Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus 21:944\u2013952. https:\/\/doi.org\/10.1177\/0961203312442259","journal-title":"Lupus"},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/08860220802353843","volume":"30","author":"GM Sahin","year":"2008","unstructured":"Sahin GM, Sahin S, Kiziltas S et al (2008) Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis. Ren Fail 30:865\u2013869. https:\/\/doi.org\/10.1080\/08860220802353843","journal-title":"Ren Fail"},{"key":"753_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4103\/1319-2442.185233","volume":"27","author":"BG Kaballo","year":"2016","unstructured":"Kaballo BG, Ahmed AE, Nur MM et al (2016) Mycophenolate mofetil versus azathioprine for maintenance treatment of lupus nephritis. Saudi J Kidney Dis Transpl 27:717\u2013725. https:\/\/doi.org\/10.4103\/1319-2442.185233","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"753_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000101448","volume":"30","author":"Z Rihova","year":"2007","unstructured":"Rihova Z, Vankova Z, Maixnerova D et al (2007) Treatment of lupus nephritis with cyclosporine\u2014an outcome analysis. Kidney Blood Press Res 30:124\u2013128. https:\/\/doi.org\/10.1159\/000101448","journal-title":"Kidney Blood Press Res"},{"key":"753_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/j.ajkd.2018.07.008","volume":"72","author":"DJ Tunnicliffe","year":"2018","unstructured":"Tunnicliffe DJ, Palmer SC (2018) Immunosuppressive treatment for proliferative lupus nephritis: summary of a cochrane review. AJKD 72:756\u2013757. https:\/\/doi.org\/10.1053\/j.ajkd.2018.07.008","journal-title":"AJKD"},{"key":"753_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/art.40930","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151\u20131159. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Ann Rheum Dis"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/sj.ki.5002118","volume":"71","author":"GS Markowitz","year":"2007","unstructured":"Markowitz GS, D'Agati VD (2007) The ISN\/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491\u2013495. https:\/\/doi.org\/10.1038\/sj.ki.5002118","journal-title":"Kidney Int"},{"key":"753_CR20","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z et al (2012) European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771\u20131782. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","journal-title":"Ann Rheum Dis"},{"key":"753_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa031855","volume":"350","author":"G Contreras","year":"2004","unstructured":"Contreras G, Pardo V, Leclercq B et al (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971\u2013980. https:\/\/doi.org\/10.1056\/NEJMoa031855","journal-title":"N Engl J Med"},{"key":"753_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00706-3","author":"V Binda","year":"2020","unstructured":"Binda V, Trezzi B, Del Papa N et al (2020) Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient). J Nephrol. https:\/\/doi.org\/10.1007\/s40620-020-00706-3","journal-title":"J Nephrol"},{"key":"753_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ndt\/gfn565","volume":"24","author":"G Moroni","year":"2009","unstructured":"Moroni G, Doria A, Ponticelli C (2009) Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrol Dial Transplant 24:15\u201320. https:\/\/doi.org\/10.1093\/ndt\/gfn565","journal-title":"Nephrol Dial Transplant"},{"key":"753_CR24","doi-asserted-by":"publisher","first-page":"e0132724","DOI":"10.1371\/journal.pone.0132724","volume":"10","author":"R Liao","year":"2015","unstructured":"Liao R, Liu Q, Zheng Z et al (2015) Tacrolimus protects podocytes from injury in lupus nephritis partly by stabilizing the cytoskeleton and inhibiting podocyte apoptosis. PLoS ONE 10:e0132724. https:\/\/doi.org\/10.1371\/journal.pone.0132724","journal-title":"PLoS ONE"},{"key":"753_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3899\/jrheum.090048","volume":"37","author":"K Suzuki","year":"2010","unstructured":"Suzuki K, Saito K, Tsujimura S et al (2010) Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis. J Rheumatol 37:512\u2013520. https:\/\/doi.org\/10.3899\/jrheum.090048","journal-title":"J Rheumatol"},{"key":"753_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","volume":"15","author":"J Hannah","year":"2016","unstructured":"Hannah J, Casian A, D\u2019Cruz D (2016) Tacrolimus use in lupus nephritis: a systematic review and meta-analysis. Autoimmun Rev 15:93\u2013101. https:\/\/doi.org\/10.1016\/j.autrev.2015.09.006","journal-title":"Autoimmun Rev"},{"key":"753_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0961203313511555","volume":"23","author":"J Z\u00e1vada","year":"2014","unstructured":"Z\u00e1vada J, Sinikka Pesickov\u00e1 S, Rysav\u00e1 R et al (2014) Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A. Lupus 23:69\u201374. https:\/\/doi.org\/10.1177\/0961203313511555","journal-title":"Lupus"},{"key":"753_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/1756-185X.13152","volume":"21","author":"N Kasitanon","year":"2018","unstructured":"Kasitanon N, Boripatkosol P, Louthrenoo W (2018) Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria. Int J Rheum Dis 21:200\u2013207. https:\/\/doi.org\/10.1111\/1756-185X.13152","journal-title":"Int J Rheum Dis"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5414\/CN109325","volume":"89","author":"TH Yang","year":"2018","unstructured":"Yang TH, Wu TH, Chang YL et al (2018) Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus. Clin Nephrol 89:277\u2013285. https:\/\/doi.org\/10.5414\/CN109325","journal-title":"Clin Nephrol"},{"key":"753_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","volume":"7","author":"HJL Heerspink","year":"2019","unstructured":"Heerspink HJL, Greene T, Tighiouart H et al (2019) Chronic Kidney Disease Epidemiology Collaboration. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol 7:128\u2013139. https:\/\/doi.org\/10.1016\/S2213-8587(18)30314-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"753_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s40620-018-0477-3","volume":"31","author":"L Colla","year":"2018","unstructured":"Colla L, Diena D, Rossetti M et al (2018) Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol 31:361\u2013383","journal-title":"J Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00753-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:37Z","timestamp":1777564477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/2\/389\/8325673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00753-w","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"9 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Fondazione Ca\u2019\nGranda IRCCS Ospedale Maggiore Policlinico di Milano, Italy (Protocol\nNumber 504_2019bis) and of the other participating centers. We\nacted in the full adherence to the Declaration of Helsinki","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed an informed consent for the scientific use of their\ndata. Patients were followed by dedicated team in each of the participating\ncenters.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}